IFT54 p.Arg565Ter
c.1693C>T · rs760692076 · VCV1025887
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 16 of 17 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.4 | GERP -2.4, phastCons 0.99 |
| Overall | ||
| CADD | 37.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,576 |
| East Asiangrpmax | 0.00223% | 44,894 |
| African / African-American | 0.00134% | 74,904 |
| European (non-Finnish) | 0.000678% | 147,470 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- IFT54
- Protein
- p.Arg565Ter
- Coding
- c.1693C>T
- MANE Select
- NM_015650
- dbSNP
- rs760692076
- Type
- single nucleotide variant
- Location
- chr2:238397462 (GRCh38)
- Structure
- AlphaFold pLDDT 61.95 · 2 PDB
- Residue 565
- the 'disc1-interaction domain' region
Disease context
Senior-Loken syndrome 9 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Senior-Loken syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- TRAF3IP1 p.Arg565Gln Uncertain significance ★★ ⚠ same residue
- IFT54 p.Gly355Glu Uncertain significance ★★ ⚠ same condition
- IFT54 p.Pro30Ser Uncertain significance ★★ ⚠ same condition
- TRAF3IP1 p.Arg271Gln Uncertain significance ★★ ⚠ same condition
- TRAF3IP1 p.Arg271Trp Uncertain significance ★★ ⚠ same condition
- TRAF3IP1 p.Arg470Trp Uncertain significance ★★ ⚠ same condition
- TRAF3IP1 p.Glu229Lys Uncertain significance ★★ ⚠ same condition
- TRAF3IP1 p.Thr588Met Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ift54-p-arg565ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown